Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Jen Liu

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Plos Neglected Tropical Diseases|September 27, 2013
Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancementChen-Yi Chiang, Chien-Hsiung Pan, Chun-Hsiang Hsieh, et al.
Molecular Cancer Therapeutics|February 2, 2011
Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancerYuh-Pyng Sher, Shih-Jen Liu, Chun-Mien Chang, et al.
Scientific Reports|July 30, 2016
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in miceChen-Yi Chiang, Chien-Hsiung Pan, Mei-Yu Chen, et al.
Microbes and Infection|April 7, 2009
Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccineMing-Hsi Huang, Chiung-Yi Huang, Su-Chen Lin, et al.
Journal of Inflammation Research|August 19, 2021
Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2Shiu-Ju Yang, Ting-Chun Wei, Chih-Hao Hsu, et al.
International Journal of Molecular Sciences|May 14, 2022
Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective ImmunityHung-Chun Liao, Wan-Ling Wu, Chen-Yi Chiang, et al.
Scientific Reports|December 13, 2017
CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responsesDa-Wei Yeh, Chao-Yang Lai, Yi-Ling Liu, et al.
Theranostics|December 22, 2025
Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathwaysChen-Yi Chiang, Ming-Shu Hsieh, Mei-Yu Chen, et al.
EMBO Reports|June 9, 2018
Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cellsJenn-Haung Lai, Mei-Yi Wang, Chuan-Yueh Huang, et al.
International Journal of Nanomedicine|February 21, 2012
Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switchChia-Hung Chen, Yu-Ling Lin, Yen-Ku Liu, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Plos Neglected Tropical Diseases|September 27, 2013
Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancementChen-Yi Chiang, Chien-Hsiung Pan, Chun-Hsiang Hsieh, et al.
Molecular Cancer Therapeutics|February 2, 2011
Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancerYuh-Pyng Sher, Shih-Jen Liu, Chun-Mien Chang, et al.
Scientific Reports|July 30, 2016
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in miceChen-Yi Chiang, Chien-Hsiung Pan, Mei-Yu Chen, et al.
Microbes and Infection|April 7, 2009
Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccineMing-Hsi Huang, Chiung-Yi Huang, Su-Chen Lin, et al.
Journal of Inflammation Research|August 19, 2021
Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2Shiu-Ju Yang, Ting-Chun Wei, Chih-Hao Hsu, et al.
International Journal of Molecular Sciences|May 14, 2022
Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective ImmunityHung-Chun Liao, Wan-Ling Wu, Chen-Yi Chiang, et al.
Scientific Reports|December 13, 2017
CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responsesDa-Wei Yeh, Chao-Yang Lai, Yi-Ling Liu, et al.
Theranostics|December 22, 2025
Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathwaysChen-Yi Chiang, Ming-Shu Hsieh, Mei-Yu Chen, et al.
EMBO Reports|June 9, 2018
Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cellsJenn-Haung Lai, Mei-Yi Wang, Chuan-Yueh Huang, et al.
International Journal of Nanomedicine|February 21, 2012
Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switchChia-Hung Chen, Yu-Ling Lin, Yen-Ku Liu, et al.
Pageof 12